- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03930836
Implementation of a New Motor Skill Learning Therapeutic Device in Children With Cerebral Palsy Rehabilitation
18. Dezember 2020 aktualisiert von: Yannick Bleyenheuft, Université Catholique de Louvain
Implementation of a New Interactive Interface Applying Motor Skill Learning Principles to Generate Motor, Functional and Neuroplastic Changes During High and Low Dosage Interventions in Children With Cerebral Palsy
Study of the efficiency of a new interactive interface to apply all the therapeutic principles of motor skill learning used in high dosage intensive interventions.
Investigation of its effects on motor, functional and neuroplastic changes in children after high and low dosage intensive interventions using or not the interface.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Studientyp
Interventionell
Einschreibung (Tatsächlich)
64
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
Brussels, Belgien, 1200
- Institute of Neuroscience, Université catholique de Louvain
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
5 Jahre bis 18 Jahre (Kind, Erwachsene)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- diagnosis of unilateral cerebral palsy
- MACS level I, II or III
- GMFCS level I, II, III
Exclusion Criteria:
- unstable seizure
- cognitive deficit that prevent understanding of simple games
- botulinic toxin injection, surgery, or another unusual intervention in the 6 months preceding the study and for the duration of the study
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: control group
high/low dosage intervention, intensive or not (motor function rehabilitation)
|
Intensive intervention focusing on a constant bimanual coordination with a lower extremities and trunk control stimulation during play and functional activities.
50% of therapeutic time will be performed using the new interactive interface
Conventional therapy (physical and occupational therapy) is mainly based on neurodevelopmental therapeutic principles.
50% of therapeutic time will be performed using the new interactive interface
|
|
Experimental: interface group
high/low dosage intensive intervention using the interactive interface (motor function rehabilitation)
|
Intensive intervention focusing on a constant bimanual coordination with a lower extremities and trunk control stimulation during play and functional activities.
50% of therapeutic time will be performed using the new interactive interface
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline Assisting Hand Assessments score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
The Assisting Hand Assessment has been developped to measure and describe the efficacy of use of the affected hand of children with unilateral cerebral palsy bimanual activity performance.
This is a standardized criterion-referenced test.
It is conducted as a recorded semi-structured play session using specific objects usually used in a bimanual manner.
With twenty-two test items, the child's performance is measured and obtain a sum score measure and a scaled score (percent scale).
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline 6 Minutes Walking Test score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Measurement developped to assess the exercise tolerance and walking abilities by asking the patient to walk as much as possible during 6 minutes in a 30 meters long corridor
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from baseline Box and Blocks test score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Test measuring hand function through the number of blocks transported in 1 minute from one part an other of a box placed in front of the child.
Each hand tested separately
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline Jebsen-Taylor Test of Hand Function score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Measure of hand function/dexterity, through 7 activities simulating daily life activities.
Each hand is tested separately and time to complete each activity is reported using a stopwatch.
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline Modified Cooper test at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Measurement of the stereognosis abilities.16
objects are placed in the hand and the child has to recognise the object only by touch.
both hands are tested separately and time to recognise the objects is reported using a stopwatch
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline ABILHAND-Kids questionnaire score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
questionnaire measuring performance of the child in daily life activities focusing on the upper extremities.
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline ACTIVLIM-CP questionnaire score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
questionnaire measuring performance of the child in daily life activities focusing on upper and lower extremities.
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline ABILOCO-Kids questionnaire at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
questionnaire measuring performance of the child in daily life activities focusing on the lower extremities.
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline Pediatric Evaluation of Disability Inventory score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
questionnaire measuring performance of the child in daily life activities focusing on the upper extremities and lower extremities.
Only the self-care domain will be assessed here
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline Canadian Occupational Performance Measure scores at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
The Canadian Occupational Performance Measure is a measure designed to capture the patient's self-perception of performance in everyday living, over time.
It consist of a semi-structured interview were the patient elicits daily life activities performed with difficulties (self-care, nutrition, transfer, household management, school, work, transport, leisure, etc).
Five activities are then chosen as the most important to improve and score on a 1 to 10 scale based on the actual patient's performance and satisfaction levels.
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
|
Change from baseline MHAVIE-child questionnaire score at 1 week post-camp
Zeitfenster: pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Questionnaire measuring social participation
|
pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
14. Juni 2018
Primärer Abschluss (Tatsächlich)
20. Juni 2020
Studienabschluss (Tatsächlich)
15. Juli 2020
Studienanmeldedaten
Zuerst eingereicht
21. Juni 2018
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
26. April 2019
Zuerst gepostet (Tatsächlich)
29. April 2019
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
21. Dezember 2020
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
18. Dezember 2020
Zuletzt verifiziert
1. Dezember 2020
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- B403201316810c
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .